- Home
- MFA vs KURA Comparison
MFA vs KURA Comparison
Compare MFA & KURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MFA
- KURA
- Stock Information
- Founded
- MFA 1997
- KURA 2014
- Country
- MFA United States
- KURA United States
- Employees
- MFA N/A
- KURA N/A
- Industry
- MFA Real Estate Investment Trusts
- KURA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- MFA Real Estate
- KURA Health Care
- Exchange
- MFA Nasdaq
- KURA Nasdaq
- Market Cap
- MFA 930.2M
- KURA 1.0B
- IPO Year
- MFA N/A
- KURA N/A
- Fundamental
- Price
- MFA $9.69
- KURA $12.08
- Analyst Decision
- MFA Buy
- KURA Buy
- Analyst Count
- MFA 7
- KURA 11
- Target Price
- MFA $10.96
- KURA $25.00
- AVG Volume (30 Days)
- MFA 1.3M
- KURA 2.2M
- Earning Date
- MFA 11-06-2025
- KURA 11-04-2025
- Dividend Yield
- MFA 14.95%
- KURA N/A
- EPS Growth
- MFA N/A
- KURA N/A
- EPS
- MFA 0.86
- KURA N/A
- Revenue
- MFA $279,011,000.00
- KURA $104,029,000.00
- Revenue This Year
- MFA N/A
- KURA $68.63
- Revenue Next Year
- MFA $14.85
- KURA $141.59
- P/E Ratio
- MFA $11.20
- KURA N/A
- Revenue Growth
- MFA N/A
- KURA N/A
- 52 Week Low
- MFA $7.85
- KURA $5.41
- 52 Week High
- MFA $11.28
- KURA $12.49
- Technical
- Relative Strength Index (RSI)
- MFA 64.52
- KURA 66.94
- Support Level
- MFA $8.94
- KURA $10.86
- Resistance Level
- MFA $9.18
- KURA $11.88
- Average True Range (ATR)
- MFA 0.18
- KURA 0.88
- MACD
- MFA 0.05
- KURA 0.08
- Stochastic Oscillator
- MFA 98.71
- KURA 85.86
About MFA MFA Financial Inc.
MFA Financial Inc is a specialty finance company that invests in and finances residential mortgage assets. Its principal business objective is to deliver shareholder value through the generation of distributable income and through asset performance linked to residential mortgage credit fundamentals. The company selectively invests in residential mortgage assets with a focus on credit analysis, projected prepayment rates, interest rate sensitivity and expected return. The company's reportable segments include mortgage-related assets and Lima One.
About KURA Kura Oncology Inc.
Kura Oncology Inc is a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer. The company's pipeline consists of small molecule drug candidates targeting cancer signaling pathways.